129 related articles for article (PubMed ID: 14611909)
1. Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis.
Wallace GR; Farmer I; Church A; Graham EM; Stanford MR
Immunol Lett; 2003 Nov; 90(1):59-64. PubMed ID: 14611909
[TBL] [Abstract][Full Text] [Related]
2. Enhanced production of macrophage inhibitory protein-1alpha in patients with Behçet's disease.
Kim WU; Do JH; Park KS; Cho ML; Park SH; Cho CS; Kim HY
Scand J Rheumatol; 2005; 34(2):129-35. PubMed ID: 16095009
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Fisher NC; Neil DA; Williams A; Adams DH
Gut; 1999 Sep; 45(3):416-20. PubMed ID: 10446112
[TBL] [Abstract][Full Text] [Related]
4. Sequential measurements of chemokines in urosepsis and experimental endotoxemia.
Olszyna DP; Prins JM; Dekkers PE; De Jonge E; Speelman P; Van Deventer SJ; Van Der Poll T
J Clin Immunol; 1999 Nov; 19(6):399-405. PubMed ID: 10634213
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
6. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M; Sato S; Takehara K
Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.
Kaburagi Y; Shimada Y; Nagaoka T; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2001 Jul; 293(7):350-5. PubMed ID: 11550808
[TBL] [Abstract][Full Text] [Related]
11. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
12. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
13. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
Rau B; Baumgart K; Krüger CM; Schilling M; Beger HG
Intensive Care Med; 2003 Apr; 29(4):622-9. PubMed ID: 12589535
[TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Hashimoto S; Nakayama T; Gon Y; Hata N; Koura T; Maruoka S; Matsumoto K; Hayashi S; Abe Y; Horie T
Clin Exp Immunol; 1998 Mar; 111(3):604-10. PubMed ID: 9528906
[TBL] [Abstract][Full Text] [Related]
15. Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris.
Dai YJ; Li YY; Zeng HM; Liang XA; Xie ZJ; Zheng ZA; Pan QH; Xing YX
Asian Pac J Trop Med; 2014 Jul; 7(7):582-4. PubMed ID: 25063291
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
[TBL] [Abstract][Full Text] [Related]
17. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury.
Jo N; Wu GS; Rao NA
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4054-60. PubMed ID: 12939328
[TBL] [Abstract][Full Text] [Related]
19. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
Andjelkovic AV; Pachter JS
J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
[TBL] [Abstract][Full Text] [Related]
20. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
